Lonza and AllCells have entered into a private label partnership for the manufacture and global commercialization of an extensive range of hematopoietic primary cells.

New findings from a Giellepi Health Science Division clinical research trial demonstrates that a mixture of probiotic strains and lactoferrin could aid in reducing the most common cause of vaginal discomfort in women.

WuXi AppTec, a leading global pharmaceutical and medical device open-access capability and technology platform company with global operations, announces the expansion of its facilities in San Diego, California.

Eisai Co., Ltd  and University College London   announced  that they have commenced preparations for Phase I clinical studies on E2814

ADC Biotechnology , announces that it has secured additional funding of £2.5 million from existing investors and company management.

Subscribe to our Newsletter
Show more
Show less
Cookies make it easier for us to provide you with our services. With the usage of our services you permit us to use cookies.
More information Ok